13F-HR filed by Gramercy Funds Management LLC
Gramercy Funds Management LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 7 holding rows worth $498,349,000.
- Accession
- 0000919574-18-003661
- Filer
- CIK 1548836
- Filed
- 2018-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, 7 entries on the cover page, a total value of $498,349,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $498,348,000 with VALUE read as thousands by filing date, 13F file number 028-14946. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ISHARES TR | 464288281 | JPMORGAN USD EMG | 2,000,000 | $225,640,000 | thousands by filing date | put |
| ISHARES TR | 464287234 | MSCI EMG MKT ETF | 4,500,000 | $217,260,000 | thousands by filing date | put |
| COSAN LTD | G25343107 | SHS A | 2,834,983 | $29,455,000 | thousands by filing date | |
| CEMEX SAB DE CV SPON ADR NEW | 151290889 | ADR | 2,463,300 | $16,307,000 | thousands by filing date | |
| AES CORP COM | 00130H105 | Stock | 659,384 | $7,497,000 | thousands by filing date | |
| VALEANT PHARMACEUTICALS INTL | 91911K102 | COM | 100,000 | $1,592,000 | thousands by filing date | call |
| VALEANT PHARMACEUTICALS INTL | 91911K102 | COM | 37,500 | $597,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-18-003661 | this filing | 2018-05-15 | acceptance time not in the bulk data set |